The Psychosocial Impact of Atopic Dermatitis

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1027)


Atopic dermatitis is a chronic skin condition which has significant psychosocial and quality of life impact. The condition causes physical discomfort, emotional distress, embarrassment, social stigma and daily activity limitation. In an effort to assess these aspects of disease burden, quality of life measurement tools were developed. Through use of these tools, we have expanded our knowledge of the psychosocial and quality of life burden of this condition. A variety of quality of life assessment tools exist, yet there is no consensus on which tool is best suited to assess the quality of life impact of atopic dermatitis. Research studies assessing quality of life in atopic dermatitis patients utilize a variety of quality of life measurement tools; this complicates comparisons across research studies. Though comparison across studies is difficult, the data echoes tremendous overall burden of disease, especially pertaining to psychosocial status and life quality.


Atopic dermatitis Quality of life index Psychosocial impact atopic dermatitis 


  1. 1.
    Lewis-Jones MS, Finlay AY. The Children’s dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132:942–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Lewis-Jones MS, Finlay AY, Dykes PJ. The infants’ dermatitis quality of life index. Br J Dermatol. 2001;144:104–10.CrossRefPubMedGoogle Scholar
  3. 3.
    Chamlin SL, Cella D, Frieden IJ, Williams ML, Mancini AJ, Lai JS, et al. Development of the childhood atopic dermatitis impact scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol. 2005a;125:1106–11.CrossRefPubMedGoogle Scholar
  4. 4.
    Smidt AC, Lai JS, Cella D, et al. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol. 2010;146:865–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin diseases: reliability, validity and responsiveness. J Invest Dermatol. 1996;107:707–13.Google Scholar
  6. 6.
    Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231–6. doi: 10.1016/j.det.2011.11.003.CrossRefPubMedGoogle Scholar
  7. 7.
    Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–40.CrossRefPubMedGoogle Scholar
  8. 8.
    Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol. 1998;138:107–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37:41–50.CrossRefPubMedGoogle Scholar
  10. 10.
    Finlay AY, Khan GK. Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Flanagan JC. A research approach to improving our quality of life. Am Psychol. 1978;33:138–47. doi: 10.1037//0003-066X.33.2.138.CrossRefGoogle Scholar
  12. 12.
    Flanagan JC. Measurement of the quality of life: current state of the art. Arch Phys Med Rehabil. 1982;63:56–9.PubMedGoogle Scholar
  13. 13.
    Anderson RT, Rajagopalan R. Effects of allergic dermatosis on health-related quality of life. Curr Allergy Asthma Rep. 2001;1:309e15.Google Scholar
  14. 14.
    Lewis-Jones S. Measuring the burden of atopic eczema in young children and the family unit. Soc Invest Dermatol. 2005;125:viii. doi: 10.1111/j.0022-202X.2005.23970.x.CrossRefGoogle Scholar
  15. 15.
    Heinl D, Prinsen CAC, Sach T, Drucker AM, Ofenloch R, Flohr C, Apfelbacher C. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review. Br J Dermatol. 2017;176(4):878–89. doi: 10.1111/bjd.1496.CrossRefPubMedGoogle Scholar
  16. 16.
    Hill MK, Pishkenari AK, Braunberger TL, Armstrong AW, Dunnick CA. Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: a systematic review. J Am Acad Dermatol. 2016;75:906–17.CrossRefPubMedGoogle Scholar
  17. 17.
    Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014;150:593e600.Google Scholar
  18. 18.
    Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155:145e5.CrossRefGoogle Scholar
  19. 19.
    Chamlin SL, Frieden IJ, Williams ML, Chren MM. Effects of atopic dermatitis on young American children and their families. Pediatrics. 2004;114:607e11.CrossRefGoogle Scholar
  20. 20.
    Kong TS, Han TY, Lee JH, Son SJ. Correlation between severity of atopic dermatitis and sleep quality in children and adults. Ann Dermatol. 2016;28(3):321–6. doi: 10.5021/ad.2016.28.3.321.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Chamlin SL, Mattson CL, Frieden IJ, et al. The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med. 2005;159:745e50.CrossRefGoogle Scholar
  22. 22.
    Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol. 2004;150:284e90.CrossRefGoogle Scholar
  23. 23.
    Ganemo A, Svensson A, Lindberg M, Wahlgren CF. Quality of life in Swedish children with eczema. Acta Derm Venereol. 2007;87:345e9.CrossRefGoogle Scholar
  24. 24.
    Ho RC, Giam YC, Ng TP, et al. The influence of childhood atopic dermatitis on health of mothers, and its impact on Asian families. Pediatr Allergy Immunol. 2010;21:501e7.CrossRefGoogle Scholar
  25. 25.
    Hon KL, Tsang YC, Pong NH, et al. Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema. J Dermatolg Treat. 2015;26:418e25.Google Scholar
  26. 26.
    Ricci G, Bendandi B, Bellini F, Patrizi A, Masi M. Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score. Pediatr Allergy Immunol. 2007;18:245e9.CrossRefGoogle Scholar
  27. 27.
    Alzolibani AA. Impact of atopic dermatitis on the quality of life of Saudi children. Saudi Med J. 2014;35:391e6.Google Scholar
  28. 28.
    Maksimovic N, Jankovic S, Marinkovic J, Sekulovic LK, Zivkovic Z, Spiric VT. Health-related quality of life in patients with atopic dermatitis. J Dermatol. 2012;39:42e7.CrossRefGoogle Scholar
  29. 29.
    Monti F, Agostini F, Gobbi F, Neri E, Schianchi S, Arcangeli F. Quality of life measures in Italian children with atopic dermatitis and their families. Ital J Pediatr. 2011;37:59.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Halvorsen JA, Lien L, Dalgard F, Bjertness E, Stern RS. Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study. J Invest Dermatol. 2014;134:1847e54.CrossRefGoogle Scholar
  31. 31.
    Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol. 2015a;135:56e66.CrossRefGoogle Scholar
  32. 32.
    Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol. 2006b;154:719e25.CrossRefGoogle Scholar
  33. 33.
    Roosta N, Black DS, Peng D, Riley LW. Skin disease and stigma in emerging adulthood: impact on healthy development. J Cutan Med Surg. 2010;14:285e90.CrossRefGoogle Scholar
  34. 34.
    Misery L, Finlay AY, Martin N, et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology. 2007;215:123e9.CrossRefGoogle Scholar
  35. 35.
    Nyren M, Lindberg M, Stenberg B, Svensson M, Svensson A, Meding B. Influence of childhood atopic dermatitis on future worklife. Scand J Work Environ Health. 2005;31:474e8.CrossRefGoogle Scholar
  36. 36.
    Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118:226e32.CrossRefGoogle Scholar
  37. 37.
    Dickel H, Bruckner TM, Schmidt A, Diepgen TL. Impact of atopic skin diathesis on occupational skin disease incidence in a working population. J Invest Dermatol. 2003;121:37e40.CrossRefGoogle Scholar
  38. 38.
    Holm EA, Esmann S, Jemec GB. The handicap caused by atopic dermatitis—sick leave and job avoidance. J Eur Acad Dermatol Venereol. 2006a;20:255e9.Google Scholar
  39. 39.
    Chrostowska-Plak D, Reich A, Szepietowski JC. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermato Venereol. 2013;27:e239e42.CrossRefGoogle Scholar
  40. 40.
    Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2012;26:236e41.CrossRefGoogle Scholar
  41. 41.
    Wittkowski A, Richards HL, Griffiths CE, Main CJ. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychomsom Res. 2004;57:195e200.Google Scholar
  42. 42.
    Beikert FC, Langenbruch AK, Radtke MA, Kornek T, Purwins S, Augustin M. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2014;306:279e86.CrossRefGoogle Scholar
  43. 43.
    Holm EA, Esmann S, Jemec GB. Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med. 2004;1:125e30.CrossRefGoogle Scholar
  44. 44.
    Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41:151e8.CrossRefGoogle Scholar
  45. 45.
    Drucker AM, Wang AR, Li WQ, et al. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26–30. doi: 10.1016/j.jid.2016.07.012.CrossRefPubMedGoogle Scholar
  46. 46.
    Warschburger P, Buchholz HT, Petermann F. Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? Br J Dermatol. 2004;150:304e11.CrossRefGoogle Scholar
  47. 47.
    Gieler U, Schoof S, Gieler T, Sibylle S, Schut C, Kupfer J. Atopic eczema and stress among single parents and families: an empirical study of 96 mothers. Acta Derm Venereol. 2017;97(1):42–6. doi: 10.2340/00015555-2457.CrossRefPubMedGoogle Scholar
  48. 48.
    Holm EA, Jemec GB. Time spent on treatment of atopic dermatitis: a new method of measuring pediatric morbidity? Pediatr Dermatol. 2004;21:623e7.CrossRefGoogle Scholar
  49. 49.
    Jemec GB, Esmann S, Holm EA, Tycho A, Jorgensen TM. Time spent on treatment (TSOT). An independent assessment of disease severity in atopic dermatitis. Acta Dermatovenerol Alp Pannonica Adriat. 2006;15:119e24.Google Scholar
  50. 50.
    Moore K, David TJ, Murray CS, Child F, Arkwright PD. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol. 2006;154:514e8.CrossRefGoogle Scholar
  51. 51.
    Schmid-Ott G, Steen T. Skin disorders and quality of life. In: Stone JH, Blouin M, editors. International encyclopedia of rehabilitation; 2010. Accessed 17 June 2016.Google Scholar
  52. 52.
    Ring J. Atopic dermatitis: eczema. Berlin: Springer; 2016.CrossRefGoogle Scholar
  53. 53.
    LeBocidge JS, Elverson RD, Timmons KG, Hawryluk EB, Rea C, Lee M, Schneider LC. Multidisciplinary interventions in the management of atopic dermatitis. J Allergy Clin Immunol. 2016;138:325–34.CrossRefGoogle Scholar
  54. 54.
    Kupfer J, Gieler U, Diepgen TL, et al. Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial. J Psychosom Res. 2010;68:353–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Schut C, Mollanazar NK, Kupfer J, Gieler U, Yosipovitch G. Psychological interventions in the treatment of chronic itch. Acta Derm Venerol. 2016;96:157–61.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Section of DermatologyReading Health Physician NetworkWyomissingUSA
  2. 2.Department of DermatologyLewis Katz School of Medicine at Temple UniversityPhiladelphiaUSA
  3. 3.Department of DermatologyWake Forest University School of MedicineWinston SalemUSA

Personalised recommendations